Home » Topics » Endocrine/metabolic, BioWorld Science

Endocrine/metabolic, BioWorld Science
RSS

NPY antagonists from Glaxo Wellcome

Sep. 20, 1996

Bristol-Myers sets up program for heart attack prevention

Sep. 20, 1996

Pierre Fabre investigates ACAT inhibitors

Sep. 20, 1996

Prevention of bone loss with alendronate

Sep. 20, 1996

Endocrine research at Toyama

Sep. 13, 1996

Endocrine R&D at Chugai

Sep. 13, 1996

A safe, effective and economical contraceptive method

Sep. 13, 1996

Danish approval for testosterone patch

Sep. 13, 1996

Orally active GH secretagogues with a short duration of action

Sep. 13, 1996

New treatment for diabetic keratopathy

Sep. 13, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 8, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 8, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...